APA (7th ed.) Citation

Rugo, H. S., Loi, S., Adams, S., Schmid, P., Schneeweiss, A., Barrios, C. H., . . . Emens, L. A. (2021). PD-L1 immunohistochemistry assay comparison in atezolizumab plus nab-paclitaxel-treated advanced triple-negative breast cancer. Journal of the National Cancer Institute, 113(12), . https://doi.org/10.1093/jnci/djab108

Chicago Style (17th ed.) Citation

Rugo, Hope S., et al. "PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus Nab-paclitaxel-treated Advanced Triple-negative Breast Cancer." Journal of the National Cancer Institute 113, no. 12 (2021). https://doi.org/10.1093/jnci/djab108.

MLA (9th ed.) Citation

Rugo, Hope S., et al. "PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus Nab-paclitaxel-treated Advanced Triple-negative Breast Cancer." Journal of the National Cancer Institute, vol. 113, no. 12, 2021, https://doi.org/10.1093/jnci/djab108.